70 related articles for article (PubMed ID: 34784933)
1. TFE3-rearranged renal cell carcinoma: A case report.
Yin Q; Liu M; Xie F; Huang R
Asian J Surg; 2024 Jun; ():. PubMed ID: 38834477
[No Abstract] [Full Text] [Related]
2. Direct-on-Target Microdroplet Growth Assay for Detection of Bacterial Resistance in Positive Blood Cultures.
Tang H; Li R; Xu H; Lu G; Liu Z; Yang W; Xia Z; Zhu Y; Shen J
Infect Drug Resist; 2021; 14():4611-4617. PubMed ID: 34785912
[TBL] [Abstract][Full Text] [Related]
3. ERK2-topoisomerase II regulatory axis is important for gene activation in immediate early genes.
Bunch H; Kim D; Naganuma M; Nakagawa R; Cong A; Jeong J; Ehara H; Vu H; Chang JH; Schellenberg MJ; Sekine SI
Nat Commun; 2023 Dec; 14(1):8341. PubMed ID: 38097570
[TBL] [Abstract][Full Text] [Related]
4. Estrogen associates with female predominance in Xp11.2 translocation renal cell carcinoma.
Lu Y; Zhu Y; Ma W; Liu N; Dong X; Shi Q; Yu F; Guo H; Li D; Gan W
Sci Rep; 2023 Apr; 13(1):6141. PubMed ID: 37061606
[TBL] [Abstract][Full Text] [Related]
5. RBM10-TFE3 renal cell carcinoma characterised by paracentric inversion with consistent closely split signals in break-apart fluorescence in-situ hybridisation: study of 10 cases and a literature review.
Kato I; Furuya M; Baba M; Kameda Y; Yasuda M; Nishimoto K; Oyama M; Yamasaki T; Ogawa O; Niino H; Nakaigawa N; Yano Y; Sakamoto K; Urata Y; Mikami K; Yamasaki S; Tanaka R; Takagi T; Kondo T; Nagashima Y
Histopathology; 2019 Aug; 75(2):254-265. PubMed ID: 30908700
[TBL] [Abstract][Full Text] [Related]
6. Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.
Inamura K
Cancers (Basel); 2017 Aug; 9(9):. PubMed ID: 28850056
[TBL] [Abstract][Full Text] [Related]
7. Estradiol increases risk of topoisomerase IIβ-mediated DNA strand breaks to initiate Xp11.2 translocation renal cell carcinoma.
Shi Q; Liu N; Yang L; Chen Y; Lu Y; Guo H; Han X; Li D; Gan W
Cell Commun Signal; 2021 Nov; 19(1):114. PubMed ID: 34784933
[TBL] [Abstract][Full Text] [Related]
8. TFE3 fusions escape from controlling of mTOR signaling pathway and accumulate in the nucleus promoting genes expression in Xp11.2 translocation renal cell carcinomas.
Yin X; Wang B; Gan W; Zhuang W; Xiang Z; Han X; Li D
J Exp Clin Cancer Res; 2019 Mar; 38(1):119. PubMed ID: 30849994
[TBL] [Abstract][Full Text] [Related]
9. Both SUMOylation and ubiquitination of TFE3 fusion protein regulated by androgen receptor are the potential target in the therapy of Xp11.2 translocation renal cell carcinoma.
Liu N; Chen Y; Yang L; Shi Q; Lu Y; Ma W; Han X; Guo H; Li D; Gan W
Clin Transl Med; 2022 Apr; 12(4):e797. PubMed ID: 35452181
[TBL] [Abstract][Full Text] [Related]
10. Newly designed break-apart and ASPL-TFE3 dual-fusion FISH assay are useful in diagnosing Xp11.2 translocation renal cell carcinoma and ASPL-TFE3 renal cell carcinoma: a STARD-compliant article.
Chen X; Yang Y; Gan W; Xu L; Ye Q; Guo H
Medicine (Baltimore); 2015 May; 94(19):e873. PubMed ID: 25984679
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-204-5p: A novel candidate urinary biomarker of Xp11.2 translocation renal cell carcinoma.
Kurahashi R; Kadomatsu T; Baba M; Hara C; Itoh H; Miyata K; Endo M; Morinaga J; Terada K; Araki K; Eto M; Schmidt LS; Kamba T; Linehan WM; Oike Y
Cancer Sci; 2019 Jun; 110(6):1897-1908. PubMed ID: 31006167
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of NMRK2 mediated by TFE3 fusions is the key for energy metabolism adaption of Xp11.2 translocation renal cell carcinoma.
Chen Y; Yang L; Lu Y; Liu N; Ma W; Fan H; Hu Q; Han X; Gan W; Li D
Cancer Lett; 2022 Jul; 538():215689. PubMed ID: 35447281
[TBL] [Abstract][Full Text] [Related]
13. PRCC-TFE3 fusion-mediated PRKN/parkin-dependent mitophagy promotes cell survival and proliferation in PRCC-TFE3 translocation renal cell carcinoma.
Wang B; Yin X; Gan W; Pan F; Li S; Xiang Z; Han X; Li D
Autophagy; 2021 Sep; 17(9):2475-2493. PubMed ID: 33019842
[TBL] [Abstract][Full Text] [Related]
14. Gender difference analysis of Xp11.2 translocation renal cell carcinomas's attack rate: a meta-analysis and systematic review.
Zhuang W; Liu N; Guo H; Zhang C; Gan W
BMC Urol; 2020 Aug; 20(1):130. PubMed ID: 32843027
[TBL] [Abstract][Full Text] [Related]
15. Cancer statistics, 2020.
Siegel RL; Miller KD; Jemal A
CA Cancer J Clin; 2020 Jan; 70(1):7-30. PubMed ID: 31912902
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
